Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

31%

4 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed with results

Key Signals

2 with results78% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (7)
Early P 1 (1)
P 1 (1)
P 3 (2)
P 4 (2)

Trial Status

Completed7
Recruiting2
Terminated2
Unknown1
Not Yet Recruiting1

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (13)

Research Network

Activity Timeline